Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
BALZAK PLUS 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- OLMESARTAN MEDOXOMILO — 40 mg
- AMLODIPINO BESILATO — 5 mg
- HIDROCLOROTIAZIDA — 12.5 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- The only pack is marketed
Packs
BALZAK PLUS 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos
28 pcs
National code
Marketed729661Strength of this pack 40 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
No official document link is published here
The authority publishes no document for this medicine.
Registration
- Registration number
- BE390564Official data
- Marketing authorisation holder
- MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.Official data
- Authorised
- Nov 3, 2020Official data
- Authority form code
- 42Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.